Lv4
414 积分 2022-10-29 加入
Deep Learning for Predicting Major Pathological Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer: A Retrospective Multicenter Study
1个月前
已完结
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer
1个月前
已完结
Dermatologist-level classification of skin cancer with deep neural networks
1个月前
已完结
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
1个月前
已完结
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
1个月前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
1个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
1个月前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1个月前
已完结
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study
1个月前
已完结
Radiomics: the bridge between medical imaging and personalized medicine
1个月前
已完结
皖公网安备34019202002308
